Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Oct 14, 2004


BioCommerce Week’s Index to the Diversified Molecular Biology Tools Companies

General Electric started off the fall financial reporting season on Friday with a 15 percent increase in overall revenues. But, GE shares fell a fraction of a percent for the weekly period ending Tuesday. The conglomerate was one of 12 companies whose shares fell among the 15 companies tracked by the BioCommerce Week index.

Bio-Rad improved 9.7 percent, to $57.72 from $52.60, while Molecular Devices was up 1.3 percent, and PerkinElmer ended up a fraction as the Index dropped in value for the second time in the last three weeks.

Overall, the Index fell a fraction of a percent led by Harvard Bio’s 6-percent dip, with its stock closing at $4.21 Tuesday, down from $4.48 last week. Agilent entered a new collaboration and its stock price fell 5.5 percent to $21.92 from $23.21.

Major market indicators — the Dow, S&P 500, and Nasdaq — all finished down approximately 1 percent for the five-day period, while the Amex biotech and pharma indices closed down approximately 4 percent.

Following is a list of when the BCW Index companies will report their financials for the quarter ending Sept. 30, updated to include GE’s Healthcare reported Q3 revenues:

  • Agilent, Q4 2004: Nov. 11, 2004
  • Applied Biosystems, Q1 2005: Oct. 25, 2004
  • Becton Dickinson, Q4 2004: Nov. 4, 2004
  • Beckman Coulter, Q3 2004: Nov. 4, 2004
  • Bio-Rad, Q3 2004: Nov. 1, 2004
  • Bruker, Q3 2004: Nov. 1, 2004
  • General Electric Healthcare, Q3 2004: $3.4 billion
  • Harvard Biosciences, Q3 2004: Oct. 25, 2004
  • Invitrogen, Q3 2004: Oct. 25, 2004
  • Molecular Devices, Q3 2004: Oct. 28, 2004
  • PerkinElmer, Q3 2004: Oct. 18, 2004,
  • Sigma-Aldrich, Q3 2004: Oct. 21, 2004
  • Stratagene, Q3 2004: Nov. 8, 2004
  • Thermo, Q2 2004: Oct. 26, 2004
  • Waters, Q3 2004: Oct. 25, 2004
File Attachments
The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.